Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
03347 TIGERMED
RT Nominal up43.980 +2.540 (+6.129%)
Latest  |  Final  |  Interim
Non-current Assets
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Investment Properties----0000
Property, plant, equip. & others----1,199,034963,030976,679701,857
Land & other Lease Assets----547,860571,186622,354473,262
Intangible Assets----3,504,0093,073,7112,761,1652,013,038
Interests in Asso. & JCEs----3,424,6032,977,0281,799,825738,799
Other Non-current Assets----13,695,82410,751,64810,181,3308,964,329

----22,371,33118,336,60116,341,35312,891,285
Current Assets
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Inventories----31,95623,39822,2046,095
Trade Receivables----1,365,7691,260,9151,033,820816,057
Cash & Bank Balances----2,055,3457,419,9927,782,7418,378,417
Other Current Assets----2,846,6152,639,8372,263,1551,649,319
Assets Held for Sale----003,2370

----6,299,68511,344,14111,105,15710,849,888
Current Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Trade Payables----257,287249,308157,958147,867
S-T Debt & Leases----2,110,5472,489,2611,985,979566,835
Other Current Liabilities----1,294,0181,400,1681,585,6321,698,014
Liab asso w/ Assets Held for Sale----0000

----3,661,8524,138,7363,729,5692,412,716
Net Current Assets----2,637,8337,205,4057,375,5888,437,172
Total Assets Less Current Liabilities----25,009,16325,542,00623,716,94121,328,457
Non-current Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
L-T Debt & Leases----722,966857,332733,617406,839
Other Non-current Liabilities----221,718231,112302,296316,421

----944,6841,088,4441,035,913723,260
Capital and Reserves
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
  Share Capital----864,949872,418872,419872,439
  Reserves----19,805,70520,154,35718,756,02617,313,024
  Others----0000
Shareholders' Funds----20,670,65321,026,77519,628,44518,185,463
Non-controlling Interests----3,393,8263,426,7873,052,5832,419,734
Others----0000

----24,064,47924,453,56222,681,02820,605,197
Commitments and Contingent Liabilities
2025/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2024/12
RMB(K¥)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
Commitments----240,461614,338777,0451,619,004
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 01/04/2026 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB 887,890
%Change119.154%
EPS / (LPS)RMB 1.040
NBV Per Share (¥)RMB --
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.